RL
Rudy Li Wolfe Research Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
36
Avg Return
Past Year
Past Year
40%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
84.6%
Neutral
15.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $40 |
52%
upside
| 2 | +18% |
0
%
| 24 Feb ‘26 10 days ago |
|
|
|
Outperform
Initiated
| $45 |
59%
upside
| 1 | -12% |
0
%
| 24 Feb ‘26 10 days ago |
|
|
|
Outperform
Initiated
| $230 |
42%
upside
| 1 | -7.6% |
0
%
| 24 Feb ‘26 10 days ago |
|
|
|
Outperform
Initiated
| $60 |
43%
upside
| 1 | +3.9% |
0
%
| 24 Feb ‘26 10 days ago |
|
|
|
Outperform
Initiated
| $40 |
15%
upside
| 1 | +72% |
0
%
| 24 Feb ‘26 10 days ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 24 Feb ‘26 10 days ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 24 Feb ‘26 10 days ago |
|
|
|
Outperform
Initiated
| $500 |
61%
upside
| 1 | +88% |
0
%
| 24 Feb ‘26 10 days ago |
|
|
|
Outperform
Initiated
| $160 |
23%
upside
| 1 | +0.98% |
0
%
| 24 Feb ‘26 10 days ago |
|
|
|
Outperform
Initiated
| $25 |
42%
upside
| 1 | +44% |
0
%
| 24 Feb ‘26 10 days ago |
|
|
|
Outperform
Initiated
| $33 |
47%
upside
| 1 | -9.4% |
0
%
| 24 Feb ‘26 10 days ago |
|
|
|
Buy
Maintained
| $80 |
3%
upside
| 1 | +51% |
0
%
| 2 Jan ‘26 2 months ago |
|